When firefighter John Casey heroically saves an elderly woman named Mrs. Parker in a terrible fire, he has no idea that this one act will change his life forever.

A mysterious letter arrives from Mrs. Parker's attorney, summoning John and his wife, Susan, to a meeting. The couple receives news they never expected. They are the sole beneficiaries of Mrs. Parker's incredible fortune, worth an estimated two billion dollars; they now own homes in Palm Beach, Boston, and New York.

With all this money comes a new challenge. As Christians, John and Susan know they need to be responsible stewards; accordingly, they give to their church and to other charities. Yet as soon as they travel to Florida to look at their new property, strange things begin to happen. Unsavory men begin following them and, unbeknownst to the couple, their own servants are involved in monitoring their every move.

As John and Susan, along with their best friends, Mark and Carol, begin to dig deeper into the Parker family history, they discover a sordid tale full of deceit, murder, demons, and angels. John and Susan must adorn the armor of God if they are to prevail over Satan's minions and emerge with their faith-and their lives-intact.

This book brings together historians from the United States, Canada, Australia, New Zealand, and Europe to historicize constructions of whiteness as a colonial formation. Confronting the privilege inherent in the invisibility of contemporary whiteness requires that the historical roots of racial power be interrogated, and the history of European colonialism is of much more than passing significance to this task. This collection functions to read the colonial back into whiteness by demonstrating how this racial category traveled around the routes of empire. It shows how a transnational focus can bring historical and spatial specificity to the study of whiteness and thus re-orients the frames of whiteness for American and non-American scholars alike.

Since the publication of the first edition, there have been advances in both the diagnosis and the management of many of the cholestatic liver diseases. Cholestatic Liver Disease, Second Edition thoroughly updates the topics previously addressed, such as primary biliary cirrhosis, primary sclerosing cholangitis, and cholestatic variants of drug hepatotoxicity and viral disease. New treatments, such as the development of the farnesoid X receptor agonists for the treatment of PBC, are highlighted. Current guidelines and areas of uncertainty are also covered. Additionally, new chapters have been added to reflect the changing landscape of cholestatic liver disease. Cholestatic Liver Disease, Second Edition is a concise yet comprehensive summary of the current status of the field and is of value to clinicians and researchers interested in patients with cholestatic liver disease provide that will help to guide patient management and stimulate investigative efforts.

Using a multi-level approach to Mark 15:34, and contra to the opinion of the majority of Markan scholarship, a contextual reading of Ps 22:2 does not serve to negate or dilute the presentation of Jesus as one in distress. Rather, such a reading enhances this aspect of his death by underscoring his identity as a Righteous Sufferer who experiences suffering but has the promise of vindication. The evidence that supports a contextual reading of the citation in the Markan narrative includes: (a) the importance of Jesus' impending resurrection/vindication and its foreshadowing; (b) the relatively consistent contextual use of the scriptures in the narrative prior to Mark 15:34; (c) the patterns of the textual and liturgical use of the psalms and the presence of the motif of the Righteous Sufferer in Mark's socio-cultural milieu; (d) the presentation of Jesus as the Righteous Sufferer throughout the narrative; and (e) an exegesis of Mark 15:34 and the surrounding Markan passion-resurrection narrative with regard to the function of Ps 22 in the story of Jesus' death and resurrection. A test case of this argument is undertaken at the close of the book, when both Matthew and Luke's treatment of Ps 22 and other Righteous Sufferer language is considered, regarding their readings of Ps 22 in Mark as the earliest tangible evidence of the interpretation of this passage in his gospel.

Play therapy and family therapy both are well established therapeutic paradigms. Often, however, play therapists have minimal contact with the nuclear family of which their child patient is a member. Similarly, family therapists frequently view young children as disruptive and exclude them from family sessions. By combining both play and family treatment modalities as this unique book Family Play Therapy suggests, all family members can participate in a therapeutic process which, in its inclusion of everyone, is more genuine and therefore successful. Family Play Therapy encourages the blending of play therapy and family therapy by discussing and demonstrating various techniques and diverse theoretical approaches that will enable readers to broaden their repertoire when working with families and their young children. Each author describes his or her own creative avenue of expression such as puppetry, psychodrama, and sandplay, which facilitate the family's communication, helping members to find new ways to hear each other. Family play therapy and play therapy need not be exclusionary. The two approaches actually can enhance and enrich each other. While each therapist ultimately will use his or her own ideas in the critical combining of both methods, Family Play Therapy offers various possibilities and as such, helps therapists to help their family patients to be readily engaged in treatment and to experience therapy as a fun, inclusive, transforming time together.

Since the publication of the first edition, there have been advances in both the diagnosis and the management of many of the cholestatic liver diseases. Cholestatic Liver Disease, Second Edition thoroughly updates the topics previously addressed, such as primary biliary cirrhosis, primary sclerosing cholangitis and cholestatic variants of drug hepatotoxicity and viral disease. New treatments, such as the development of the farnesoid X receptor agonists for the treatment of PBC, are highlighted. Current guidelines and areas of uncertainty are also covered. Additionally, new chapters have been added to reflect the changing landscape of cholestatic liver disease. Cholestatic Liver Disease, Second Edition is a concise yet comprehensive summary of the current status of the field and is of value to clinicians and researchers interested in patients with cholestatic liver disease provide that will help to guide patient management and stimulate investigative efforts.

The Guest Editors have put together an issue of clinical reviews that provides the most current look at PBC. Authors, all experts in their respective areas, have submitted articles in the following areas: Changes in epidemiology of PBC; Genetic and epigenetics in PBC; Role of bile acids and the bicarbonate umbrella in the pathogenesis of PBC; Current treatment options in PBC; Work in progress: Drugs in development; Natural history of PBC in the UDCA era: Role of scoring systems; Treatment of Pruritus: Tricks of the trade; Chronic complications of cholestasis: Work-up and Management; Individualizing care: Management beyond medical therapy; Role of liver biopsy: When to do, how to stage; AMA-negative PBC: Is it really the same as AMA-positive PBC?; New thoughts on Overlap syndrome with auto-immune hepatitis; and Current status of liver transplantation for PBC.

This Is A New Release Of The Original 1880 Edition.

This is a new release of the original 1930 edition.